Retinal autoantibody profile in early age-related macular degeneration: Preliminary findings from the Blue Mountains Eye Study

Clinical and Experimental Ophthalmology

Volumn 34, Issue 6, 2006, Pages 590-595

  Cherepanoff, Svetlana ^a,c   Mitchell, Paul ^a,b   Wang, Jie Jin ^a,b   Gillies, Mark C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

Autoantibody; Blindness; Macular degeneration; Serum; Western blot

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; POLYPEPTIDE; RETINA ANTIGEN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FISHER EXACT TEST; HUMAN; IMMUNOPATHOGENESIS; MALE; MOLECULAR WEIGHT; RETINA MACULA AGE RELATED DEGENERATION; SAMPLE SIZE; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; DISEASE PROGRESSION; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEW SOUTH WALES; RETINA;

EID: 33747347186     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01281.x     Document Type: Article

References (38)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-43.
2. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995; 102: 1450-60.
3. Penfold PL, Madigan MC, Gilles MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res 2001; 20: 385-414.
4. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001; 20: 705-32.
5. Penfold P, Killingsworth M, Sarks S. An ultrastructural study of the role of leucocytes and fibroblasts in the breakdown of Bruch's membrane. Aust J Ophthalmol 1984; 12: 23-31.
6. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration: The involvement of immunocompetent cells. Graefes Arch Clin Exp Ophthalmol 1985; 223: 69-76.
7. Penfold PL, Killingsworth MC, Sarks SH. Senile macular degeneration. The involvement of giant cells in atrophy of the retinal pigment epithelium. Invest Ophthalmol Vis Sci 1986; 27: 364-71.
8. Penfold PL, Provis JM, Billson FA. Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 1987; 225: 70-6.
9. Sarks JP, Sarks SH, Killingsworth MC. Morphology of early choroidal neovascularisation in age-related macular degeneration: Correlation with activity. Eye 1997; 11: 515-22.
10. Ambati J, Anand A, Fernandez S et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 2003; 9: 1390-7.
11. Tuo J, Smith BC, Bojanowski et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J 2004; 18: 1297-9.
12. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-4.
13. Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005; 308: 419-21.
14. Hageman GS, Anderson DH, Johnson LV et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 2005; 102: 7227-32.
15. Klein RJ, Zeiss C, Chew EY. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-9.
16. Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1990; 228: 270-4.
17. Chen H, Wu L, Pan S, Wu DZ. An immunologic study on age-related macular degeneration. Yen Ko Hsueh Pao [Eye Sci] 1993; 9: 113-20.
18. Gurne DH, Tso MO, Edward DP, Ripps H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 1991; 98: 602-7.
19. Patel N, Ohbayashi M, Nugent AK et al. Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology 2005; 115: 422-30.
20. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991; 98: 1128-34.
21. Gu X, Meer SG, Miyagi M et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem 2003; 278: 42027-35.
22. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995; 7: 812-18.
23. Lacroix-Desmazes S, Kaveri SV, Mouthon L et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods 1998; 216: 117-37.
24. Joachim SC, Grus FH, Pfeiffer N. Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur J Ophthalmol 2003; 13: 752-8.
25. Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N. Complex autoantibody repertoires in patients with glaucoma. Mol Vis 2004; 10: 132-7.
26. Zarbin MA. Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 2004; 122: 598-614.
27. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 2000; 14: 835-46.
28. Hageman GS, Mullins RF. Molecular composition of drusen as related to substructural phenotype. Mol Vis 1999; 5: 28.
29. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DA. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 2000; 70: 441-9.
30. Newsome DA, Hewitt AT, Huh W, Robey PG, Hassell JR. Detection of specific extracellular matrix molecules in drusen, Bruch's membrane, and ciliary body. Am J Ophthalmol 1987; 104: 373-81.
31. Cohen J, Bakimer R, Blank M, Valesini G, Shoenfeld Y. Pathogenic natural anti-cardiolipin antibodies: The experience from monoclonal gammopathy. Clin Exp Immunol 1994; 97: 181-6.
32. Carayannopoulos MO, Potter KN, Li Y, Natvig JB, Capra JD. Evidence that human immunoglobulin M rheumatoid factors can Be derived from the natural autoantibody pool and undergo an antigen driven immune response in which somatically mutated rheumatoid factors have lower affinities for immunoglobulin G Fc than their germline counterparts. Scand J Immunol 2000; 51: 327-36.
33. Forrester JV, Lumsden L, Liversidge J, Kuppner M, Mesri M. Immunoregulation of uveoretinal inflammation. Prog Retin Eye Res 1995; 14: 393-412.
34. Zareparsi S, Buraczynska M, Branham KEH. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005; 14: 1449-55.
35. Shaw PX, Horkko S, Chang M-K. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000; 105: 1731-40.
36. Binder CJ, Horkko S, Dewan A. Pneumococcal vaccination decreases atherosclerotic lesion formation: Molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003; 9: 736-43.
37. Crabb JW, Miyagi M, Gu X. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002; 99: 14682-7.
38. Quintana FJ, Cohen IR. The natural autoantibody repertoire and autoimmune disease. Biomed Pharmacother 2004; 58: 276-81.